ZOBONE

This brand name is authorized in Brazil, Ecuador, Singapore, South Africa

Active ingredients

The drug ZOBONE contains one active pharmaceutical ingredient (API):

1 Zoledronic acid UNII 70HZ18PH24 - ZOLEDRONIC ACID ANHYDROUS

Zoledronic acid belongs to the class of bisphosphonates and acts primarily on bone. It is an inhibitor of osteoclastic bone resorption. Read about Zoledronic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZOBONE Concentrate for solution for infusion	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M05BA08	Zoledronic acid	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 532413070009903
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 360-MEE-0614
Country: SG	Health Sciences Authority	Identifier(s): 15562P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 42/34/0664